5Adamson PC,Balis FM,Belasco JE,et al.721） and mlphalan in children with refractory cancer[].Cancer Research.1995
6Lynn M,Schucher.Guidelines for the Administration of Amifostine[].Seminn Oncol.1996
7Wadler S,Haynes H,Beitler JJ,et al.Management of hypocalcemic effects of WR2721 administered on a daily times five schedule with cisplatin and radiation therapy[].Journal of Clinical Oncology.1993
2KOUVARIS JR, KOULOULIAS VE, VLAHOS LJ. Amifostine: the first selective-target and broad-spectrum radioprotector [ J 1. Oncologist, 2007, 12 ( 6 ): 738.
3YBH00012009国家药品标准[S],2009.
4USP 38-NF 33 [S]. 2015:2165.
5KORST AEC, BOVEN E, van der STERRE MLT, et al. Influence of single and multiple doses of amifostine on the efficacy and the pharmacokinetics of earboplatin in mice [ J]. British J Cancer, 1997,75 ( 10 ): 1439.
6JAHNUKAINEN K, JAHNUKAINEN T, SALMI TT, et al. Amifostine protects against early but not late toxic effects of doxorubicin in infant rats[ J ]. Cancer Res. , 2001,61 ( 17 ): 6423.
7van der WILT CL, van LAAR JA, GYERGYA'Y F, et al. Biochemical modification of the toxicity and the anti-turnout effect of 5-fluorouracil and cis-platinum by WR-2721 in mice [ J ]. Eur J Cancer, 1992, 28A ( 12 ): 2017.
8GLOVER D, NEGENDANK W, DELIVORIA-PAPADOPOULOS M, et al. Alterations in oxygen transport following WR-2721 [ J ]. Int J Radiat Oncol Biol Phys, 1984, 10( 9 ): 1565.
9KOUKOURAKIS MI, GIATROMANOLAKI A, CHONG W, et al. Amifostine induces anaerobic metabolism and hypoxia-inducible factor 1 alpha [ J]. Cancer Chemother Pharmacol, 2004, 53 ( 1 ): 8.
10PANDIT JJ, ALLEN C, LITTLE E, et al. Does amifostine reduce metabolic rate?Effect of the drug on gas exchange and acute ventilatory hypoxic response in humans [ J ]. Pharmaceuticals ( Basel ), 2015,8 ( 2 ): 186.
